Clinical Trial: Study to Compare Bioavailability and Pharmacokinetics of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80 mg) Administered Intravenously in Healthy Volunteers

U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269496) titled 'Study to Compare Bioavailability and Pharmacokinetics of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80 mg) Administered Intravenously in Healthy Volunteers' on Nov. 18.

Brief Summary: The trial is to compare the bioavailability of the original European Lasix (furosemide injection) administered in accordance with its prescribing information with the same dose of a novel furosemide formulation developed for this subcutaneous administration. The study will also investigate PK and PD of these regimens.

Study Start Date: Jan. 15, 2026

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG:...